Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00690170 · ClinicalTrials.gov registry record · Phase 1
Nicotinic Modulation of Schizophrenia-like Information Processing Deficits in Healthy Subjects
A Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00690170 is a Phase 1 study that has completed, run by Yale University. The registered enrollment target is 30 participants.
The verdict
NCT00690170, a Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study examines the interactive effects of ketamine and nicotine.
Interventions
- DRUG Placebo
- DRUG Ketamine
- DRUG Nicotine
- DRUG Ketamine and Nicotine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2002-12 |
| Est. Completion | 2009-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00690170
The ClinicalTrials.gov registry entry for NCT00690170 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00690170 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00690170 about?
NCT00690170 is a clinical study titled "Nicotinic Modulation of Schizophrenia-like Information Processing Deficits in Healthy Subjects". This study examines the interactive effects of ketamine and nicotine.
What is the current status of trial NCT00690170?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2002-12. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00690170?
The interventions under investigation include: Placebo (DRUG), Ketamine (DRUG), Nicotine (DRUG), Ketamine and Nicotine (DRUG).
Who is sponsoring clinical trial NCT00690170?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.